Disc Medicine, Inc. (IRON)
68.42
-0.07
(-0.10%)
USD |
NASDAQ |
Sep 22, 16:00
68.42
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine Total Assets (Quarterly) : 735.07M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 735.07M |
| March 31, 2026 | 750.21M |
| December 31, 2025 | 806.88M |
| September 30, 2025 | 630.46M |
| June 30, 2025 | 665.06M |
| March 31, 2025 | 709.27M |
| December 31, 2024 | 496.77M |
| September 30, 2024 | 495.14M |
| June 30, 2024 | 510.22M |
| March 31, 2024 | 354.18M |
| December 31, 2023 | 368.00M |
| September 30, 2023 | 376.50M |
| June 30, 2023 | 384.17M |
| Date | Value |
|---|---|
| March 31, 2023 | 243.78M |
| December 31, 2022 | 200.20M |
| September 30, 2022 | 106.03M |
| June 30, 2022 | 113.33M |
| March 31, 2022 | 124.28M |
| December 31, 2021 | 92.41M |
| September 30, 2021 | 155.54M |
| June 30, 2021 | 172.42M |
| March 31, 2021 | 189.38M |
| December 31, 2020 | 8.319M |
| September 30, 2020 | 122.36M |
| June 30, 2020 | 0.078M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.213B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.91M |
| Shareholders Equity (Quarterly) | 644.16M |
| Debt to Equity Ratio | 0.0945 |
| Current Ratio | 24.14 |
| Net Debt Paydown Yield | -0.22% |